Already a member? Sign in
Category: Over the Counter Drugs
Most Popular Types: Imodium, Imodium A-D, Maalox Anti-Diarrheal
Generic Name: Loperamide
Loperamide is an antidiarrheal drug used to treat chronic diarrhea associated with inflammatory bowel disease; acute nonspecific diarrhea; increased volume of ileostomy discharge, traveler’s diarrhea.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| IBS (Irritable Bowel Syndrome) | 110 | 7 |
|
|
|
|
|
| Diarrhea | 32 | 8 |
|
|
|
|
|
| Bowel problems | 6 | 3 |
|
|
|||
| Bowel irritability | 3 | 1 |
|
||||
| Other | 3 | 0 | |||||
| Microscopic Colitis | 2 | 0 |
See all 100 patients currently taking Loperamide
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Loperamide
| Constipation | 1 | |
|---|---|---|
| Abdominal bloating | 1 | |
| Stomach pain | 1 | |
| Somnolence | 1 | |
| Gas pain | 1 | |
| Occasional hard bloody stool | 1 |
Frequently reported dosages based on patients currently taking Loperamide. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 28 | ||
| Course of treatment ended | 20 | ||
| Did not seem to work | 14 | ||
| Side effects too severe | 9 | ||
| Doctor's advice | 9 | ||
| Personal research | 2 | ||
| Not indicated | 2 | ||
| Expense | 1 |
Adherence
Taking treatment as prescribed
Adherence of Loperamide
Always |
10 | 50% |
|
|---|---|---|---|
Usually |
6 | 30% |
|
Sometimes |
3 | 15% |
|
Never |
1 | 5% |
|
Burden
Difficulty being on treatment
Burden of Loperamide
Very |
1 | 5% |
|
|---|---|---|---|
Somewhat |
3 | 15% |
|
A little |
3 | 15% |
|
Not at all |
13 | 65% |
|
Cost
Paid out of pocket
Cost of Loperamide
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
12 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 26, 2012.